Paul A DiSilvestro Selected Research

Paul A DiSilvestro Research Topics

14	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 09/2002
10	Carcinoma (Carcinomatosis) 04/2024 - 12/2006
9	Neoplasms (Cancer) 10/2020 - 01/2007
6	Ovarian Epithelial Carcinoma 08/2020 - 02/2016
4	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2010
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2016 - 12/2006
3	Disease Progression 02/2016 - 09/2002
2	Nausea 04/2024 - 12/2019
2	Carcinosarcoma 01/2022 - 06/2014
2	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2020
2	Thrombocytopenia (Thrombopenia) 12/2019 - 02/2016
2	Anemia 12/2019 - 02/2016
2	Carcinogenesis 04/2019 - 01/2019
2	Neutropenia 02/2016 - 02/2016
1	Pain (Aches) 04/2024
1	Vomiting 04/2024
1	Neoplasm Micrometastasis 11/2021
1	Vulvar Neoplasms (Vulvar Cancer) 11/2021
1	Body Weight (Weight, Body) 10/2020
1	Breast Neoplasms (Breast Cancer) 02/2020
1	Fatigue 12/2019
1	Hypertension (High Blood Pressure) 02/2016
1	Fallopian Tube Neoplasms 02/2016
1	Sepsis (Septicemia) 02/2016
1	Microsatellite Instability 01/2016
1	Flatulence 08/2002

10	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 09/2002
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 09/2002
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2006
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2016
5	Proteins (Proteins, Gene)FDA Link 05/2019 - 01/2016
4	Bevacizumab (Avastin)FDA Link 10/2020 - 02/2016
4	PlatinumIBA 01/2019 - 01/2007
2	veliparibIBA 12/2019 - 02/2016
2	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 05/2019 - 01/2019
2	liposomal doxorubicin (Doxil)FDA Link 02/2016 - 01/2007
1	pembrolizumabIBA 04/2024
1	ElectrolytesIBA 04/2024
1	epacadostatIBA 04/2024
1	Ifosfamide FDA LinkGeneric 01/2022
1	TubulinIBA 10/2020
1	fosbretabulin (combretastatin A4)IBA 10/2020
1	Angiogenesis InhibitorsIBA 10/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Proteasome InhibitorsIBA 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	1-dodecylpyridoxal (PLD)IBA 02/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015
1	pazopanib FDA Link 06/2014
1	Tirapazamine (SR 4233)IBA 02/2014
1	Docetaxel (Taxotere)FDA Link 12/2012
1	Trastuzumab (Herceptin)FDA Link 01/2010

11	Drug Therapy (Chemotherapy) 01/2022 - 09/2002
9	Therapeutics 10/2020 - 09/2002
5	Radiotherapy 11/2021 - 12/2006
4	Chemoradiotherapy 01/2022 - 02/2014
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2007
1	Lymph Node Excision (Lymph Node Dissection) 11/2021
1	Salpingo-oophorectomy 02/2020
1	Induction Chemotherapy 12/2019
1	Adjuvant Chemotherapy 01/2019
1	Brachytherapy 01/2019
1	Consolidation Chemotherapy 01/2007
1	Length of Stay 08/2002